Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm	Not yet recruiting	Phase 1 / Phase 2	2024-02-14		NCT06180499

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Assistance Publique - Hôpitaux de Paris	985

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials